To ensure clinically appropriate, cost-effective use of two new cholesterol-lowering drugs, Express Scripts (NASDAQ: ESRX) today announced it will include ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE